Core Scientific, Inc. $CORZ Shares Acquired by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC boosted its position in Core Scientific, Inc. (NASDAQ:CORZFree Report) by 108.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,305,498 shares of the company’s stock after buying an additional 1,198,020 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Core Scientific were worth $34,490,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CORZ. AQR Capital Management LLC lifted its holdings in Core Scientific by 106.1% during the 1st quarter. AQR Capital Management LLC now owns 283,432 shares of the company’s stock worth $2,052,000 after buying an additional 145,905 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Core Scientific by 180.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,109,387 shares of the company’s stock valued at $8,032,000 after acquiring an additional 714,388 shares during the last quarter. Cetera Investment Advisers increased its holdings in shares of Core Scientific by 200.0% in the 2nd quarter. Cetera Investment Advisers now owns 38,819 shares of the company’s stock valued at $663,000 after acquiring an additional 25,878 shares during the last quarter. Franklin Resources Inc. acquired a new stake in shares of Core Scientific during the 2nd quarter valued at approximately $181,000. Finally, Russell Investments Group Ltd. raised its position in shares of Core Scientific by 61.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock valued at $67,000 after acquiring an additional 1,507 shares in the last quarter.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. B. Riley Financial raised their price objective on Core Scientific from $30.00 to $33.00 and gave the stock a “buy” rating in a research note on Wednesday, May 27th. BTIG Research reiterated a “buy” rating and set a $38.00 target price on shares of Core Scientific in a research note on Tuesday. Capital One Financial set a $33.00 target price on shares of Core Scientific in a report on Thursday. Lucid Cap Mkts upgraded shares of Core Scientific to a “strong-buy” rating in a research report on Friday, June 12th. Finally, Sanford C. Bernstein restated an “outperform” rating and issued a $32.00 price target on shares of Core Scientific in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $31.68.

Check Out Our Latest Stock Report on CORZ

Core Scientific Trading Down 5.0%

NASDAQ:CORZ opened at $20.72 on Friday. The stock has a 50 day moving average of $25.07 and a 200-day moving average of $20.81. The firm has a market capitalization of $6.66 billion, a PE ratio of -4.69 and a beta of 5.50. Core Scientific, Inc. has a 52 week low of $12.60 and a 52 week high of $30.46.

Core Scientific (NASDAQ:CORZGet Free Report) last announced its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analyst estimates of $144.83 million. As a group, analysts predict that Core Scientific, Inc. will post -1.3 EPS for the current fiscal year.

Insider Buying and Selling

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of the stock in a transaction on Monday, July 27th. The stock was sold at an average price of $20.95, for a total value of $209,500.00. Following the sale, the insider directly owned 1,989,101 shares of the company’s stock, valued at $41,671,665.95. This trade represents a 0.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last ninety days, insiders sold 90,000 shares of company stock worth $2,234,900. 1.70% of the stock is owned by corporate insiders.

About Core Scientific

(Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

Read More

Want to see what other hedge funds are holding CORZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Scientific, Inc. (NASDAQ:CORZFree Report).

Institutional Ownership by Quarter for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.